title: Availability of medical countermeasures for bioterrorism events: US legal and regulatory options.
authors.affiliation: Office of Counterterrorism and Emerging Threats, US Food and Drug Administration, US Department of Health and Human Services, Rockville, Maryland, USA. carmen.maher@fda.hhs.gov
authors.forename: C
authors.initials: C
authors.lastname: Maher
authors.forename: B D
authors.initials: BD
authors.lastname: Lushniak
mesh_terms: D023482:Bioterrorism / Q000331:legislation & jurisprudence*; D004189:Disaster Planning / Q000331:legislation & jurisprudence / Q000458:organization & administration*; D017277:Drug Approval; D004630:Emergencies; D006297:Health Services Accessibility / Q000331:legislation & jurisprudence / Q000458:organization & administration*; D006801:Humans; D016365:Liability, Legal; D014481:United States; D014486:United States Food and Drug Administration